Therapy‐related chronic myeloid leukemia in a patient receiving peptide receptor radionuclide therapy for pancreatic neuroendocrine tumor

BACKGROUND: Therapy‐related leukemia is a well‐recognized clinical syndrome. Peptide receptor radionuclide therapy (PRRT) is a modern therapeutic approach using radionuclide combined with somatostatin analog peptide for inoperable or metastatic neuroendocrine tumors. AIMS: Hematologic toxicities inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucukyurt, Selin, Yagiz Ozogul, Yeliz, Ercaliskan, Abdulkadir, Kabasakal, Levent, Eskazan, Ahmet Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941585/
https://www.ncbi.nlm.nih.gov/pubmed/32896091
http://dx.doi.org/10.1002/cnr2.1282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941585/
https://www.ncbi.nlm.nih.gov/pubmed/32896091
http://dx.doi.org/10.1002/cnr2.1282

Ejemplares similares